Poly-L-Lysine-Based αGal-Glycoconjugates for Treating Anti-αGal IgE-Mediated Diseases.
Olivera-Ardid S, Bello-Gil D, Tuzikov A, Araujo RN, Ferrero-Alves Y, García Figueroa BE, Labrador-Horrillo M, García-Pérez AL, Bovin N, Mañez R.
Olivera-Ardid S, et al. Among authors: bello gil d.
Front Immunol. 2022 Mar 31;13:873019. doi: 10.3389/fimmu.2022.873019. eCollection 2022.
Front Immunol. 2022.
PMID: 35432370
Free PMC article.